Literature DB >> 34733120

Estimation and Optimization of Composite Outcomes.

Daniel J Luckett1, Eric B Laber2, Siyeon Kim3, Michael R Kosorok4.   

Abstract

There is tremendous interest in precision medicine as a means to improve patient outcomes by tailoring treatment to individual characteristics. An individualized treatment rule formalizes precision medicine as a map from patient information to a recommended treatment. A treatment rule is defined to be optimal if it maximizes the mean of a scalar outcome in a population of interest, e.g., symptom reduction. However, clinical and intervention scientists often seek to balance multiple and possibly competing outcomes, e.g., symptom reduction and the risk of an adverse event. One approach to precision medicine in this setting is to elicit a composite outcome which balances all competing outcomes; unfortunately, eliciting a composite outcome directly from patients is difficult without a high-quality instrument, and an expert-derived composite outcome may not account for heterogeneity in patient preferences. We propose a new paradigm for the study of precision medicine using observational data that relies solely on the assumption that clinicians are approximately (i.e., imperfectly) making decisions to maximize individual patient utility. Estimated composite outcomes are subsequently used to construct an estimator of an individualized treatment rule which maximizes the mean of patient-specific composite outcomes. The estimated composite outcomes and estimated optimal individualized treatment rule provide new insights into patient preference heterogeneity, clinician behavior, and the value of precision medicine in a given domain. We derive inference procedures for the proposed estimators under mild conditions and demonstrate their finite sample performance through a suite of simulation experiments and an illustrative application to data from a study of bipolar depression.

Entities:  

Keywords:  Individualized treatment rules; Inverse reinforcement learning; Precision medicine; Utility functions

Year:  2021        PMID: 34733120      PMCID: PMC8562677     

Source DB:  PubMed          Journal:  J Mach Learn Res        ISSN: 1532-4435            Impact factor:   5.177


  46 in total

1.  Doubly-robust dynamic treatment regimen estimation via weighted least squares.

Authors:  Michael P Wallace; Erica E M Moodie
Journal:  Biometrics       Date:  2015-04-08       Impact factor: 2.571

2.  A Generalization Error for Q-Learning.

Authors:  Susan A Murphy
Journal:  J Mach Learn Res       Date:  2005-07       Impact factor: 3.654

3.  Estimation and extrapolation of optimal treatment and testing strategies.

Authors:  James Robins; Liliana Orellana; Andrea Rotnitzky
Journal:  Stat Med       Date:  2008-10-15       Impact factor: 2.373

4.  Randomized, Double-Blinded, Placebo-controlled Multicenter Adaptive Phase 1-2 Trial of GC 4419, a Dismutase Mimetic, in Combination with High Dose Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (PC).

Authors:  S Hoffe; J M Frakes; T A Aguilera; B Czito; M Palta; M Brookes; C Schweizer; L Colbert; S Moningi; M S Bhutani; S Pant; C W Tzeng; R S Tidwell; P Thall; Y Yuan; E C Moser; J Holmlund; J Herman; C M Taniguchi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-11-18       Impact factor: 7.038

5.  Residual Weighted Learning for Estimating Individualized Treatment Rules.

Authors:  Xin Zhou; Nicole Mayer-Hamblett; Umer Khan; Michael R Kosorok
Journal:  J Am Stat Assoc       Date:  2017-05-03       Impact factor: 5.033

6.  Personalized Dose Finding Using Outcome Weighted Learning.

Authors:  Guanhua Chen; Donglin Zeng; Michael R Kosorok
Journal:  J Am Stat Assoc       Date:  2017-01-04       Impact factor: 5.033

7.  The long-term natural history of the weekly symptomatic status of bipolar I disorder.

Authors:  Lewis L Judd; Hagop S Akiskal; Pamela J Schettler; Jean Endicott; Jack Maser; David A Solomon; Andrew C Leon; John A Rice; Martin B Keller
Journal:  Arch Gen Psychiatry       Date:  2002-06

8.  Learning Optimal Personalized Treatment Rules in Consideration of Benefit and Risk: with an Application to Treating Type 2 Diabetes Patients with Insulin Therapies.

Authors:  Yuanjia Wang; Haoda Fu; Donglin Zeng
Journal:  J Am Stat Assoc       Date:  2017-03-31       Impact factor: 5.033

9.  Incorporating Patient Preferences into Estimation of Optimal Individualized Treatment Rules.

Authors:  Emily L Butler; Eric B Laber; Sonia M Davis; Michael R Kosorok
Journal:  Biometrics       Date:  2017-07-25       Impact factor: 1.701

Review 10.  Abuse and misuse of antidepressants.

Authors:  Elizabeth A Evans; Maria A Sullivan
Journal:  Subst Abuse Rehabil       Date:  2014-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.